Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 6, 2012, Pages

  Wang, Wen ^a   Feng, Lin ^a   Zhang, Honghai ^a   Hachy, Stephanie ^a   Satohisa, Seiro ^a   Laurent, Louise C ^b   Parast, Mana ^c   Zheng, Jing ^d   Chen, Dong Bao ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN RECEPTOR B2; EPHRIN RECEPTOR B4; LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 17; MICRORNA 20A; MICRORNA 20B; RNA PRECURSOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; EPHB4 GENE; EPHRIN B2 GENE; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; PATHOGENESIS; PLACENTA DEVELOPMENT; PREECLAMPSIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SYNCYTIOTROPHOBLAST;

EPHRIN-B2; FEMALE; GENE EXPRESSION PROFILING; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LUCIFERASES; MICRORNAS; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RECEPTOR, EPHB4; UP-REGULATION;

EID: 84861960170     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-3131     Document Type: Article

References (42)

1. Redman CW, Sargent IL 2005 Latest advances in understanding preeclampsia. Science 308:1592-1594 (Pubitemid 40807500)
2. Kanasaki K, Kalluri R 2009 The biology of preeclampsia. Kidney Int 76:831-837
3. Roberts JM, Cooper DW 2001 Pathogenesis and genetics of preeclampsia. Lancet 357:53-56
4. Enquobahrie DA, Meller M, Rice K, Psaty BM, Siscovick DS, Williams MA 2008 Differential placental gene expression in preeclampsia. Am J Obstet Gynecol 199:566.e1-566.e11
5. Sitras V, Paulssen RH, Grønaas H, Leirvik J, Hanssen TA, Vårtun A, Acharya G 2009 Differential placental gene expression in severe preeclampsia. Placenta 30:424-433
6. Mouillet JF, Chu T, Sadovsky Y 2011 Expression patterns of placental microRNAs. Birth Defects Res A Clin Mol Teratol 91:737-743
7. Chelbi ST, Vaiman D 2008 Genetic and epigenetic factors contribute to the onset of preeclampsia. Mol Cell Endocrinol 282:120-129
8. Kulkarni A, Chavan-Gautam P, Mehendale S, Yadav H, Joshi S 2011 Global DNA methylation patterns in placenta and its association with maternal hypertension in pre-eclampsia. DNA Cell Biol 30:79-84
9. Bartel DP 2009 MicroRNAs: target recognition and regulatory functions. Cell 136:215-233
10. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, Sharon E, Spector Y, Bentwich Z 2005 Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37:766-770 (Pubitemid 41754896)
11. Baek D, Villén J, Shin C, Camargo FD, Gygi SP, Bartel DP 2008 The impact of microRNAs on protein output. Nature 455:64-71
12. Zhang C 2008 MicroRNomics: a newly emerging approach for disease biology. Physiol Genomics 33:139-147 (Pubitemid 351629522)
13. Cudihy D, Lee RV 2009 The pathophysiology of pre-eclampsia: current clinical concepts. J Obstet Gynaecol 29:576-582
14. Wang S, Olson EN 2009 Angiomi Rs - key regulators of angiogenesis. Curr Opin Genet Dev 19:205-211
15. Wu F, Yang Z, Li G 2009 Role of specific microRNAs for endothelial function and angiogenesis. Biochem Biophys Res Commun 386:549-553
16. George EM, Granger JP 2011 Endothelin: key mediator of hypertension in preeclampsia. Am J Hypertens 24:964-969
17. Powe CE, Levine RJ, Karumanchi SA 2011 Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123:2856-2869
18. Red-Horse K, Kapidzic M, Zhou Y, Feng KT, Singh H, Fisher SJ 2005 EPHB4 regulates chemokine-evoked trophoblast responses: a mechanism for incorporating the human placenta into the maternal circulation. Development 132:4097-4106 (Pubitemid 41488859)
19. 2007 Clinical management guidelines for obstetrician-gynecologists. ACOG Practice Bulletin. Vol. II, no. 23, January 2002. Washington, DC: American College of Obstetricians and Gynecologists; 640-648
20. Zhang HH, Feng L, Livnat I, Hoh JK, Shim JY, Liao WX, Chen DB 2010 Estradiol-17β stimulates specific receptor and endogenous nitric oxide-dependent dynamic endothelial protein S-nitrosylation: analysis of endothelial nitrosyl-proteome. Endocrinology 151:3874-3887
21. Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone JR, Jaenisch R, Sharp PA, Jacks T 2008 Targeted deletion reveals essential and over-lapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132:875-886 (Pubitemid 351312807)
22. Mayor-Lynn K, Toloubeydokhti T, Cruz AC, Chegini N 2011 Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reprod Sci 18:46-56
23. Hu Y, Li P, Hao S, Liu L, Zhao J, Hou Y 2009 Differential expression of microRNAs in the placentae of Chinese patients with severe preeclampsia. Clin Chem Lab Med 47:923-929
24. Zhu XM, Han T, Sargent IL, Yin GW, Yao YQ 2009 Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am J Obstet Gynecol 200:661.e1-661.e7
25. Enquobahrie DA, Abetew DF, Sorensen TK, Willoughby D, Chidambaram K, Williams MA 2011 Placental microRNA expression in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 204:178.e12-178.e21
26. Noack F, Ribbat-Idel J, Thorns C, Chiriac A, Axt-Fliedner R, Diedrich K, Feller AC 2011 miRNA expression profiling in formalin-fixed and paraffin-embedded placental tissue samples from pregnancies with severe preeclampsia. J Perinat Med 39: 267-271
27. Scicchitano MS, Dalmas DA, Bertiaux MA, Anderson SM, Turner LR, Thomas RA, Mirable R, Boyce RW 2006 Preliminary comparison of quantity, quality, and microarray performance of RNAextracted from formalin-fixed, paraffin-embedded, and unfixed frozen tissue samples. J Histochem Cytochem 54:1229-1237 (Pubitemid 44623343)
28. Pineles BL, Romero R, Montenegro D, Tarca AL, Han YM, Kim YM, Draghici S, Espinoza J, Kusanovic JP, Mittal P, Hassan SS, Kim CJ 2007 Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol 196:261.e1-261.e6
29. Espinoza J, Uckele JE, Starr RA, Seubert DE, Espinoza AF, Berry SM 2010 Angiogenic imbalances: the obstetric perspective. Am J Obstet Gynecol 203:17.e1-17.e8
30. Kuijper S, Turner CJ, Adams RH 2007 Regulation of angiogenesis by Eph-ephrin interactions. Trends Cardiovasc Med 17:145-151 (Pubitemid 46898841)
31. Mosch B, Reissenweber B, Neuber C, Pietzsch J 2010 Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesis. J Oncol 2010:135285
32. Kim YH, Hu H, Guevara-Gallardo S, Lam MT, Fong SY, Wang RA 2008 Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis. Development 135:3755-3764
33. Wang HU, Chen ZF, Anderson DJ 1998 Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93:741-753 (Pubitemid 28257581)
34. Sawamiphak S, Seidel S, Essmann CL, Wilkinson GA, Pitulescu ME, Acker T, Acker-Palmer A 2010 Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature 465:487-491
35. Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, Sakakibara A, Adams S, Davy A, Deutsch U, Lüthi U, Barberis A, Benjamin LE, Mäkinen T, Nobes CD, Adams RH 2010 Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465:483-486
36. Chennakesava CS, Di Santo S, Ziemiecki A, Schneider H, Andres AC 2006 Differential expression of the receptor tyrosine kinase EphB4 and its ligand Ephrin-B2 during human placental development. Placenta 27:959-967 (Pubitemid 44204026)
37. Goldman-Wohl D, Greenfield C, Haimov-Kochman R, Ariel I, Anteby EY, Hochner-Celnikier D, Farhat M, Yagel S 2004 Eph and ephrin expression in normal placental development and preeclampsia. Placenta 25:623-630 (Pubitemid 38950315)
38. Pringle KG, Kind KL, Sferruzzi-Perri AN, Thompson JG, Roberts CT 2010 Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy. Hum Reprod Update 16:415-431
39. Sounni NE, Janssen M, Foidart JM, Noel A 2003 Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis. Matrix Biol 22:55-61 (Pubitemid 36444507)
40. Kuhnert F, Kuo CJ 2010 miR-17-92 angiogenesis micromanagement. Blood 115:4631-4633
41. Lei Z, Li B, Yang Z, Fang H, Zhang GM, Feng ZH, Huang B 2009 Regulation of HIF-1α and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS One 4:e7629
42. Baggiolini M, Walz A, Kunkel SL 1989 Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045-1049 (Pubitemid 19247571)